EM · Vasoactive drugs in resuscitation
Vasoactive drugs in resuscitation
Also known as Vasopressors and inotropes · Inotropes in shock · Catecholamine therapy · Pressor use in the shocked patient
Vasoactive drugs in resuscitation — the receptor pharmacology that decides which agent to reach for (noradrenaline alpha-greater-than-beta is the first-line vasopressor of septic and most distributive shock; adrenaline the alpha-plus-beta agent of anaphylaxis and cardiac arrest; vasopressin the V1-receptor catecholamine-sparing adjunct of septic shock; dopamine avoided because of SOAP II; dobutamine the beta-1 inotrope of cardiogenic shock; milrinone the selective PDE-3 inodilator useful for the right heart and the pulmonary vasculature), the selection of the agent by the shock type and the haemodynamic phenotype, the peripheral-versus-central administration question, and the full weight-based dosing reference. The landmark trials are SOAP II (noradrenaline over dopamine), VASST and VANISH (vasopressin), SEPSISPAM (the MAP target), APROCCHSS (hydrocortisone as the catecholamine-sparing adjunct), CLOVERS (the early vasopressor versus the early fluid) and the Surviving Sepsis Campaign 2021 framework. ACEM-primary, globally tagged.
Checked against its sources on 2 Sept 2026
Practise this topic
On this page
Study tools
Your progress
Saved on this device.
Target exams
Red flags
- Noradrenaline is the first-line vasopressor for septic and most distributive shock — dopamine is no longer first-line because of the higher arrhythmia rate in SOAP II
- Anaphylaxis is treated with intramuscular adrenaline into the anterolateral thigh, not a vasopressor infusion — the dose is 0.5 mg of 1:1000, repeated every five minutes
- Vasopressin is a catecholamine-sparing adjunct, never a first-line pressor and never titrated above 0.04 units per minute — it carries a risk of mesenteric and digital ischaemia
- A peripheral vasopressor is acceptable as a temporising measure in the shocked patient who needs the pressure now — do not delay the pressor for the central line, but plan the central access early
- Extravasation of noradrenaline is an emergency — stop the infusion, aspirate, leave the cannula in situ, and inject phentolamine 5 to 10 mg in 10 mL saline subcutaneously around the site within twelve hours
- Milrinone is renally cleared — halve the dose in the acute kidney injury, and beware the refractory hypotension because the half-life is hours, not minutes
- Adrenaline raises the lactate through beta-2-driven aerobic glycolysis — a rising lactate on an adrenaline infusion is not by itself a sign of worsening shock
Meet the patient
A 62-year-old with community-acquired pneumonia is brought in cold, clammy and confused after 30 mL/kg of crystalloid on the ward. MAP 52, lactate 4.6, heart rate 124, a peripheral cannula still in his antecubital fossa. The registrar wants to site a central line before giving anything.[6]
The question that decides his next hour is the question that decides every shocked patient: is problem pressure (vasoplegia), the pump (cardiogenic), or the pipe (obstruction)? In this man it is the pressure — and the next move is noradrenaline through the cannula already in his arm, not a delay for the line.[6]
References11ShowHide
- [1]De Backer D, Biston P, Devriendt J, et al. Comparison of dopamine and norepinephrine in the treatment of shock (SOAP II). New England Journal of Medicine, 2010.PMID 20200382
- [2]Russell JA, Walley KR, Singer J, et al. Vasopressin versus norepinephrine infusion in patients with septic shock (VASST). New England Journal of Medicine, 2008.PMID 18305265
- [3]Gordon AC, Mason AJ, Thirunavukkarasu N, et al. Effect of Early Vasopressin vs Norepinephrine on Kidney Failure in Patients With Septic Shock (VANISH). JAMA, 2016.PMID 27483065
- [4]Asfar P, Meziani F, Hamel JF, et al. High versus low blood-pressure target in patients with septic shock (SEPSISPAM). New England Journal of Medicine, 2014.PMID 24635770
- [5]Annane D, Renault A, Brun-Buisson C, et al. Hydrocortisone plus Fludrocortisone for Adults with Septic Shock (APROCCHSS). New England Journal of Medicine, 2018.PMID 29490185
- [6]Evans L, Rhodes A, Alhazzani W, et al. Surviving sepsis campaign: international guidelines for management of sepsis and septic shock 2021. Intensive Care Medicine, 2021.PMID 34599691
- [7]National Heart, Lung, and Blood Institute PETAL Clinical Trials Network; Shapiro NI, Douglas IS, et al. Early Restrictive or Liberal Fluid Management for Sepsis-Induced Hypotension (CLOVERS). New England Journal of Medicine, 2023.PMID 36688507
- [8]Simons FER, et al. World Allergy Organization Anaphylaxis Guidelines: 2013 update of the evidence base. International Archives of Allergy and Immunology, 2013.PMID 24008815
- [9]St-Onge M, et al. Treatment for calcium channel blocker poisoning: a systematic review. Clinical Toxicology (Philadelphia), 2014.PMID 25283255
- [10]Australian and New Zealand Committee on Resuscitation. ANZCOR Guideline 11.5 – Medications in Adult Cardiac Arrest. ANZCOR, 2026.Source
- [11]Venkatesh B, Finfer S, Cohen J, et al. Adjunctive Glucocorticoid Therapy in Patients with Septic Shock (ADRENAL). New England Journal of Medicine, 2018.PMID 29347874